TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

Objective: to study the time course of changes in laboratory biomarkers in patients with rheumatoid arthritis (RA) 2, 4, and 8 weeks after the initiation of tocilizumab (TCZ) therapy. Subjects and methods. Forty-two RA patients receiving two intravenous infusions of TCZ (8 mg/kg each) at a 4-week in...

书目详细资料
Main Authors:	E N Aleksandrova, E Yu Panasyuk, A S Avdeyeva, A A Novikov, G V Lukina, M V Cherkasova, N V Klimova, E L Nasonov
格式:	文件
语言:	Russian
出版:	IMA PRESS LLC 2011-06-01
丛编:	Научно-практическая ревматология
主题:	rheumatoid arthritis, interleukin-6 interleukin-6 receptors tocilizumab, erythrocyte sedimentation rate c-reactive protein, igm/iga rheumatoid factor anti-cyclic citrullinated peptide antibodies anti-modified citrullinated vimentin antibodies
在线阅读:	https://rsp.mediar-press.net/rsp/article/view/705

相似书籍

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
由: Anastasia Sergeyevna Avdeyeva, et al.
出版: (2012-06-01)

Bone destruction in rheumatoid arthritis: role of autoantibodies
由: Anastasia Sergeyevna Avdeyeva, et al.
出版: (2013-06-01)

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
由: Elena Nikolayevna Aleksandrova, et al.
出版: (2012-02-01)

DIAGNOSTIC MARKERS AND CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING DMARDS
由: Maria Sergeevna Voronina, et al.
出版: (2012-10-01)

Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
由: Somayye Norouzi, et al.
出版: (2020-08-01)

New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)
由: Evgeniy L'vovich Nasonov, et al.
出版: (2010-05-01)

Correlation between anti-mutated citrullinated vimentin and bone turnover markers (CTX-1 and P1NP) in patients with rheumatoid arthritis in remission and low-disease activity
由: Tulus Widiyanto, et al.
出版: (2022-08-01)

Methotrexate-induced changes in the concentration of antibodies to modified citrulnated vimentin in blood serum of patients with rheumatoid arthritis
由: Natal'ya Petrovna Shilkina, et al.
出版: (2011-05-01)

Serum sirtuin-1 a potential marker in the diagnosis of rheumatoid arthritis
由: Liming Tan, et al.
出版: (2023-12-01)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
由: Nicole H. Trier, et al.
出版: (2019-06-01)

Assessment of the Correlation between Disease Activity and Serum Biomarker Anti-MCV and IL6 in Iraqi Patients with Rheumatoid Arthritis
由: Dania A. Ali, et al.
出版: (2024-10-01)

Rheumatoid factor and antibodies against cyclic citrullinated peptide in patients without rheumatoid arthritis
由: N. V. Bunchuk
出版: (2023-01-01)

Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
由: E N Aleksandrova, et al.
出版: (2004-12-01)

Epitope Specificity of Anti-Citrullinated Protein Antibodies
由: Nicole H. Trier, et al.
出版: (2017-03-01)

Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis
由: Akio Umemoto, et al.
出版: (2023-02-01)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
由: Hui-Chun Yu, et al.
出版: (2019-01-01)

Specificity of Anti-Citrullinated Protein Antibodies to Citrullinated α-Enolase Peptides as a Function of Epitope Structure and Composition
由: Ilaria Fanelli, et al.
出版: (2021-07-01)

Antibodies against citrullinated proteins in relation to periodontitis with or without rheumatoid arthritis: a cross-sectional study
由: Pit Hui Lew, et al.
出版: (2021-07-01)

Different clinical relevance of anti-citrullinated proteins antibodies in RA patients
由: A. S. Avdeeva, et al.
出版: (2022-05-01)

INHIBITION OF INTERLEUKIN 6 IN IMMUNE INFLAMMATORY RHEUMATIC DISEASES: ACHIEVEMENTS, PROSPECTS, AND HOPES
由: E. L. Nasonov, et al.
出版: (2018-01-01)

Tocilizumab (Actemra)
由: Martin Sheppard, et al.
出版: (2017-09-01)

Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production
由: Hisakata Yamada, et al.
出版: (2020-04-01)

Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
由: Alireza Sadeghi, et al.
出版: (2017-04-01)

Type-III interferons and rheumatoid arthritis: Correlation between interferon lambda 1 (interleukin 29) and antimutated citrullinated vimentin antibody levels
由: Diana Castillo-Martínez, et al.
出版: (2017-02-01)

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
由: S.L.E. Ribeiro, et al.
出版: (2008-11-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
由: V. V. Badokin, et al.
出版: (2011-06-01)

When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
由: Marino Paroli, et al.
出版: (2023-10-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
由: Damjanovska Ljubinka, et al.
出版: (2007-01-01)

INVESTIGATION OF CANDIDATE GENE POLYMORPHISMS IN AN IMMUNE RESPONSE AS MARKERS FOR THE RISK OF DEVELOPING RHEUMATOID ARTHRITIS AND PRODUCING AUTOANTIBODIES
由: I. A. Guseva, et al.
出版: (2016-03-01)

THE 2016 EULAR GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EARLY ARTHRITIS
由: E. L. Nasonov
出版: (2017-04-01)

The clinical aspect of overweight on rheumatoid arthritis and disease activity
由: Haitham Ahmed, et al.
出版: (2019-06-01)

Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis
由: Lakshmi Deepika Yarlagadda, et al.
出版: (2020-01-01)

Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis
由: Alessandra Zaccardelli, et al.
出版: (2019-11-01)

Cerebrovascular reactivity depending on rheumatoid factor and anticitrullinated protein antibody positivity in hypertensive patients with rheumatoid arthritis
由: N. V. Rebrova, et al.
出版: (2022-07-01)

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
由: E Yu Panasyuk, et al.
出版: (2011-08-01)

THE CLINICAL AND DIAGNOSTIC VALUE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN EARLY JUVENILEARTHRITIS
由: S O Salugina, et al.
出版: (2009-06-01)

Multicenter, observational clinical study of abatacept in Japanese patients with rheumatoid arthritis
由: Noriyoshi Ogawa, et al.
出版: (2019-01-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies, adenosine deaminase activity and other potential biomarkers for predicting and monitoring rheumatoid arthritis
由: Mehanović-Nikolić Jasminka, et al.
出版: (2008-01-01)

An assessment of anti-citrullinated protein antibody in systemically healthy individuals with or without chronic periodontitis: A case–control study
由: Ankita Rajaram Yadav, et al.
出版: (2020-01-01)

DIAGNOSTIC VALUE OF ANTI-PEPTIDYLARGININE DEIMINASE TYPE 4 (PADI-4) AND ANTI- CITRULLINATED PEPTIDE ANTIBODIES (ACCP) IN IRAQI PATIENTS WITH RHEUMATOID ARTHRITIS
由: Hassan J Hasony, et al.
出版: (2014-06-01)